Search - tctmd.com

Displaying 961 - 980 of 1307

Sort: Relevancy | Date

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Daily News

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Yael L. Maxwell

October 09, 2015

News Daily News

防护帽、患者防护服能够大幅减少手术医生的辐射接触量

Yael L. Maxwell

October 07, 2015

News Daily News

El gorro, y la Protección del Paciente Reducen Ostensiblemente la Exposición del Operador a la Radiación

Yael L. Maxwell

October 07, 2015

News Daily News

Cap, Patient Shield Provide Substantial Reductions in Operator Radiation Exposure

Yael L. Maxwell

October 07, 2015

Presentation

RCT of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap

Presenter: A. Alazzoni

October 06, 2015

News Industry News

Occlutech obtains European CE Approval for its novel mVSD Device

September 30, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

Presentation Aortovascular 2015

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

Presenter: Michael R. Jaff

September 18, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

September 16, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Yael L. Maxwell

September 01, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

Advertisement

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

防护帽、患者防护服能够大幅减少手术医生的辐射接触量

El gorro, y la Protección del Paciente Reducen Ostensiblemente la Exposición del Operador a la Radiación

Cap, Patient Shield Provide Substantial Reductions in Operator Radiation Exposure

RCT of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap

Occlutech obtains European CE Approval for its novel mVSD Device

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

Registry Charts Trends in Mechanical Circulatory Support During PCI

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content